ArticleJCO oncology practice2021

Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States.

Soledad Jorge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.